Hinesburg, MA, United States of America

Robert Martell

This inventor holds 1 USPTO granted patent. Top assignee: Curis, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Martell. Retrieved from https://idiyas.com/inventor/robert-martell-5k5s697g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Robert Martell

Introduction

Robert Martell is an accomplished inventor based in Hinesburg, MA (US). He has made significant contributions to the field of cancer treatment through his innovative approaches. His work focuses on developing combination therapies that enhance the effectiveness of cancer treatments.

Latest Patents

Robert Martell holds a patent for "Combination therapies for the treatment of cancer." This patent outlines methods for treating certain diseases and disorders, particularly cancer, using a combination of an IRAK4 inhibitor, a BCL-2 inhibitor, and a nucleoside analog. This innovative approach aims to improve patient outcomes and provide more effective treatment options.

Career Highlights

Martell is currently associated with Curis, Inc., a company dedicated to advancing innovative cancer therapies. His work at Curis has positioned him as a key player in the development of new treatment modalities that target cancer more effectively.

Collaborations

Some of his notable coworkers include Reinhard Von Roemeling and Andrey Ugolkov. Their collaborative efforts contribute to the ongoing research and development of groundbreaking cancer therapies.

Conclusion

Robert Martell's contributions to cancer treatment through his innovative patent and work at Curis, Inc. highlight the importance of collaboration and creativity in the fight against cancer. His dedication to improving patient care through combination therapies is commendable and reflects the ongoing advancements in medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…